In vitro anti-MRSA activity of a series of 35 metronidazole-triazole hybrids was reported against 30 different MRSA strains.
One compound evaluated along with oxacillin and showed synergistic activity.
Compounds were nontoxic up to 50 μM concentration against THP-1 cell lines.
The time-kill kinetics studies suggested the compounds to be bacteriostatic.
In silico studies, compounds showed good docking scores and pharmacokinetic properties and follow the Lipinski's rule of 5.